Annual Conference Midwest

Location: Rosemont, IL
Date: October 15-19, 2013

Meeting Overview

Venue:
Donald E. Stephens Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

What’s most important to you is important to us.

The demands and challenges you face every day within your practice are constantly changing, so we’re changing with you.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference, beginning with Pri‑Med Midwest this fall.

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we will be unveiling an entirely new cutting-edge CME curriculum. The CME sessions will include the latest treatments and therapies, such as:

  • Obesity in America, presented by the Dietary Counselor and Lifestyle Coach from “The Biggest Loser”
  • High Yield Office Interventions for Common Orthopedic Aches and Pains
  • ID Updates in Office-Based Primary Care
  • Test Your Skills in Difficult Cases: Nephrology (Chronic Renal Failure), Hypertension, and Atrial Fibrillation

View the full session schedule»

But that’s not all…

In addition to over 35 new educational sessions, there are many new components of the conference that were created with you in mind.

  • Three renowned Keynote Speakers including Dr Michael Dansinger, a weight loss and nutrition consultant for NBC’s “The Biggest Loser.”
  • SAFE Opioid Prescribing track featuring a faculty meet and greet and book signing
  • Easy access to syllabus slides pre-show and the ability to purchase a full set of printed slides
  • The opportunity to earn AANP contact hours of continuing education

Earn between 25.75 and 27 AMA PRA Category 1 Credits™ or AANP contact hours of continuing education.†

Register Today

Register for Pri‑Med Midwest by: Your price**
June 14 $30
August 9 $40
September 20 $55
October 12 $75
Onsite at Pri‑Med Midwest $100
Save Meeting to Your Calendar

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Price represents online registration; registration by phone is an additional $10.

†Earn between 25.75 and 27 AMA PRA Category 1 Credits™ or AANP contact hours of continuing education October 16–19, 2013, at Primary Care Updates and Annual Conference. Earn up to an additional 9 credits on October 15, 2013, at Primary Care Updates and Integrated Approaches to Cardiometabolic Care; seating is extremely limited for these two programs.

Comprehensive CME Program
Pri-Med doctor

Primary Care Updates*
October 15, 2013 | Morning
CME sessions that focus on cardiometabolic disease-specific treatment and management approaches. Seating is extremely limited.

Integrated Approaches to Cardiometabolic Care
October 15, 2013 | Afternoon
Innovative new CME sessions for PCPs, cardiologists, and endocrinologists who jointly manage patients with complex cardiometabolic conditions. Case studies, lectures, and a panel discussion will cover treatment decisions for high-risk patients.

Primary Care Updates*
October 16, 2013
A multi-track day of CME programs to supplement your education.

Annual Conference
October 17–19, 2013
An entirely new cutting-edge CME curriculum developed in collaboration with the American College of Physicians.

Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core ACP curriculum.


Industry-sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours. Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.

Registration for symposia and presentation theaters will open on August 20, 2013.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

 

Sessions & Syllabus

View Schedule for:
CLOSE  X  
Registration & Continental Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Clinical Perspectives in Diabetes: Risk Reduction Approaches and Treatment Priorities
Glycemic control is the foundation of effective diabetes care, and studies suggest that intensive efforts to control blood sugar can alleviate the health consequences of diabetes, at least for individuals who have not yet developed serious comorbidities. Primary care physicians, as frontline clinicians, are best positioned to recognize and manage risk factors for diabetes as well as patients with pre-diabetes or diabetes in their patient populations. This session will assess the complexities of dysglycemia as well as clinical strategies in primary care for patients not at glycemic target goals based on comparison of risks, benefits and utility of montherapy and combination therapy with antihyperglycemic agents in affecting adherence and glycemic control.
CLOSE  X  
Obesity: New Insights and Evidence on Intervention Strategies
National survey data indicate that the incidence of diagnosed diabetes in the United States has increased rapidly and that obesity is a major contributor to the increased risk of morbidity and mortality associated with diabetes and related cardiovascular complications. Life-style modifications and therapeutic interventions have been demonstrated to have positive impact on obesity. This session will provide for the evidence related to the benefits and risks associated with these interventions as well as patient-oriented clinical tools that primary care clinicians can use in their practice to improve patient outcomes.
CLOSE  X  
Networking Break
CLOSE  X  
Session Information to Come
CLOSE  X  
Interactive Panel: Connecting the Needs of Primary Care Clinicians, Cardiologists, and Endocrinologists in the Care of the Complex Cardiometabolic Patient - Translating the Data into Practice
In-depth update on evidence-based algorithms for cardiometabolic care-endocrinologist, cardiologist and primary care perspectives; Case presentation to translate evidence to practice from risk management to diagnosis to intervention to monitoring to patient adherence; Best approaches for patient-centered collaborative specialist and primary care providers for effective and efficient management of cardiometabolic patients.
CLOSE  X  
Networking Break
CLOSE  X  
Case-Based Learning: Focus on Abnormalities of Lipids and Hypertension in the Obese Patient
Real-world challenging case to advance the assessment, diagnosis, stratification and management of cardiometabolic risks, addressing endocrinologist, cardiologist and primary care challenges and opportunities; Dissecting linkages between dyslipidemia, hypertension and obesity; Incorporation of new and best practices in pharmacologic and non-pharmacologic interventions; Getting patients to goal through integrated care approaches
CLOSE  X  
Case-Based Learning: Focus on Dysglycemia and Renal Function in the Cardiometabolic Patient
Case in practice exploring the complexities of addressing dysglycemia and renal function in the cardiometabolic patient; Analysis of evidence-based pharmacologic and non-pharmacologic approaches, including life-style modifications, anti-glycemic monotherapy and combination therapies, interventions based on renal function and dysfunction; Advancing patient adherence through incorporation of of clinically validated tools into practice
CLOSE  X  
Networking Break
CLOSE  X  
Call to Action: Integrated Care for Managing the Complexities of Cardiometabolic Diseases
Defining insights from the day’s interactive curriculum and findings from case studies and application to clinical practice for endocrinologists, cardiologists and primary care; Culmination in “call to action” for better collaborative and patient-centered care in the diagnosis and management of the complex cardiometabolic patient
CLOSE  X  
Faculty & Attendee Networking Reception
Primary Care Updates
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
6:30 AM-7:30 AM - Registration & Continental Breakfast
 
 
 
7:30 AM-7:45 AM - Opening Remarks
7:45 AM-9:15 AM
Clinical Perspectives in Diabetes: Risk Reduction Approaches and Treatment Priorities
 
 
 
 
 
9:15 AM-10:45 AM
Obesity: New Insights and Evidence on Intervention Strategies
 
 
 
 
 
10:45 AM-11:00 AM - Networking Break
11:00 AM-12:30 PM
Session Information to Come
 
 
 
 
 
Integrated Approaches to Cardiometabolic Care
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:00PM
 
12:30 PM-2:00 PM
Interactive Panel: Connecting the Needs of Primary Care Clinicians, Cardiologists, and Endocrinologists in the Care of the Complex Cardiometabolic Patient - Translating the Data into Practice
 
 
 
 
 
2:00 PM-2:15 PM - Networking Break
2:15 PM-3:15 PM
Case-Based Learning: Focus on Abnormalities of Lipids and Hypertension in the Obese Patient
 
 
 
 
3:30 PM-4:30 PM
Case-Based Learning: Focus on Dysglycemia and Renal Function in the Cardiometabolic Patient
 
 
 
4:30 PM-4:45 PM - Networking Break
4:45 PM-5:45 PM
Call to Action: Integrated Care for Managing the Complexities of Cardiometabolic Diseases
 
 
 
5:45 PM-6:30 PM
Faculty & Attendee Networking Reception
 
 
CLOSE  X  
Session Information to Come
CLOSE  X  
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
Learning Objectives:
  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
CLOSE  X  
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: Individualized Management in Primary Care
Learning Objectives:
  1. Describe pathophysiologic mechanisms in BPH-LUTS and relationships to comorbid conditions and therapeutic approaches
  2. Conduct comprehensive assessments of patients with suspected BPH and associated LUTS
  3. Evaluate the mechanisms of action and clinical profiles of a-blockers, 5-ARIs, and PDE5 inhibitors in the treatment of BPH-LUTS with and without ED
  4. Combine pharmacologic and nonpharmacologic interventions for BPH-LUTS based on symptom severity, common comorbidities, risk of disease progression, and patient goals
  5. Monitor treatment efficacy and adherence in patients with BPH-LUTS to guide therapeutic restructuring and optimize patient outcomes
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Session Information to Come
CLOSE  X  
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin
Learning Objectives:
  1. Apply strategies to individualized therapy in the treatment of patients with type 2 diabetes
  2. Incorporate appropriate strategies for timely initiation, selection, titration, and self-management of basal insulin in patients with type 2 diabetes
  3. Describe the similarities and differences between individual GLP-1 receptor agonists
  4. Summarize the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes
CLOSE  X  
AM Break
CLOSE  X  
Session Information to Come
CLOSE  X  
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes
Learning Objectives:
  1. Evaluate and apply current evidence regarding GLP-1 RA efficacy relative to other agents and across diabetes progression
  2. Evaluate and apply current evidence regarding safety of GLP-1 RAs, including recent data on specific label precautions (eg, thyroid cancer, pancreatitis, renal failure) and cardiovascular disease
  3. Evaluate and apply current evidence regarding tolerability and treatment satisfaction with GLP-1 RAs
  4. Evaluate and apply current evidence regarding nonglycemic effects of GLP-1 RAs (eg, effects on weight, blood pressure, lipid levels)
  5. Educate patients on the causes, symptoms, and risks associated with hypoglycemia and implement new models of care to overcome patient and system barriers to therapeutic regimen adherence
CLOSE  X  
Session Information to Come
CLOSE  X  
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
Learning Objectives:
  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Insulin Replacement Therapy for Type 2 Diabetes: Patient-Centered Management of Hyperglycemia in Primary Care
Learning Objectives:
  1. Discuss the multisystem consequences of T2DM and the rationale for appropriate screening, early diagnosis, and prompt treatment
  2. Establish individualized treatment goals for patients with T2DM according to disease duration, age, comorbidities, and ongoing evaluations of hemoglobin A1C, blood glucose profiles, and therapeutic responses
  3. Employ evidence-based frameworks and new treatment approaches to individualize basal and mealtime insulin therapies across diverse T2DM patient populations
  4. Integrate patient-specific clinical and psychosocial factors into comprehensive treatment plans that include lifestyle modifications and pharmacologic interventions for T2DM
  5. Educate patients with T2DM about the importance of treatment adherence and the risks of insulin-related hypoglycemia
CLOSE  X  
Session Information to Come
CLOSE  X  
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
Learning Objectives:
  1. Identify and evaluate patients with obesity by using parameters such as body mass index, waist circumference, and risk factor assessment
  2. Engage patients in open dialogues, highlighting the importance of lifestyle modification including decreased energy intake and exercise as part of a healthy lifestyle
  3. Confidently utilize pharmacologic agents to reinforce lifestyle change for patients with obesity and obesity-related comorbid conditions
CLOSE  X  
PM Break
CLOSE  X  
Tackling the Toughest Issues and Cases of Hypertriglyceridemia
Learning Objectives:
  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors
  2. Apply best practices in the attainment of TG levels, including the role of fasting and nonfasting states in accurate evaluation
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidence-based practices and accepted guidelines
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk
CLOSE  X  
PM Break
CLOSE  X  
PM Break
CLOSE  X  
Depression: When Medical and Psychiatric Factors Collide
Learning Objectives:
  1. Identify the relationship between depression and medical factors (inflammatory, endocrine, metabolic)
  2. Select optimal treatments for patients with depression and comorbid medical conditions
  3. Assess the potential utility of biomarkers in the diagnosis and treatment of depression
CLOSE  X  
Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians
Learning Objectives:
  1. Describe fundamental pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet therapies
  2. Discuss efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials
  3. Identify therapies to reduce risk and recognize goals to achieve in the management of patients who have experienced an acute coronary syndrome
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Novo Nordisk Inc., Vivus and PamLab.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Vivus, Lilly USA, LLC and Amarin Corporation plc.
Primary Care Updates Track 3
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 3: Vivus and sanofi-aventis U.S. Inc.
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
7:45 AM-9:00 AM
Session Information to Come
7:45 AM-9:15 AM
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: Individualized Management in Primary Care
7:45 AM-9:00 AM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
   
   
   
   
9:00 AM-9:15 AM - AM Break
 
9:00 AM-9:15 AM - AM Break
9:15 AM-10:45 AM
Session Information to Come
9:15 AM-9:30 AM - AM Break
9:15 AM-10:45 AM
Complementary Therapies to Improve Glucose Control in Type 2 Diabetes: Role of GLP-1 Receptor Agonists & Basal Insulin
 
9:30 AM-10:45 AM
Session Information to Come
 
   
   
   
   
10:45 AM-12:15 PM
Case Work: Evaluating GLP-1 Receptor Agonists in Patient-Centered Care for Type 2 Diabetes
10:45 AM-12:00 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
10:45 AM-12:15 PM
Session Information to Come
   
   
   
   
 
12:00 PM-12:45 PM - Lunch
 
12:15 PM-1:00 PM - Lunch
 
12:15 PM-1:00 PM - Lunch
   
 
12:45 PM-2:15 PM
Insulin Replacement Therapy for Type 2 Diabetes: Patient-Centered Management of Hyperglycemia in Primary Care
 
1:00 PM-2:30 PM
Weighing the Consequences: The Time Is Now for Tackling the Obesity Epidemic
 
1:00 PM-2:30 PM
Session Information to Come
   
   
   
   
 
2:15 PM-2:30 PM - PM Break
 
2:30 PM-2:45 PM - PM Break
2:30 PM-3:45 PM
Tackling the Toughest Issues and Cases of Hypertriglyceridemia
2:30 PM-2:45 PM - PM Break
2:45 PM-4:00 PM
Depression: When Medical and Psychiatric Factors Collide
 
2:45 PM-4:15 PM
Reducing Risk in the Acute Coronary Syndrome Patient: Insights for Primary Care Clinicians
   
   
   
   
   
CLOSE  X  
Registration and Breakfast
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Faculty:
  1. Michael Dansinger, MD
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
What's New in Cardiovascular Medicine
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
What's New in Cardiovascular Medicine
CLOSE  X  
Lunch and Additional Opportunities
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Common Psychiatric Disorders in Primary Care
CLOSE  X  
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Common Psychiatric Disorders in Primary Care
CLOSE  X  
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Networking Break
CLOSE  X  
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
Primary Care Considerations for Patients with Cancer Treatment History
CLOSE  X  
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Screen Smarter: Providing Customized, Prioritized Cancer Screening for Your Patients
Primary Care Considerations for Patients with Cancer Treatment History:
CLOSE  X  
Medical Knowledge: Brain Game
 
 Curriculum developed in collaboration with
 
 SAFE Opioid Prescribing | Strategies. Assessment. Fundamentals. Education.
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Breakfast
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:30 AM - Networking Break and Additional Opportunities
 
 
9:30 AM-10:30 AM
Targeting Better Cardiac Outcomes for High-Risk Patients
9:30 AM-11:30 AM
Live Demonstration Orthopedic Exam: See It, Do it
 
 
 
10:30 AM-11:30 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
 
 
 
11:30 AM-1:30 PM - Lunch and Additional Opportunities
 
 
 
 
 
 
 
1:30 PM-2:30 PM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
1:30 PM-2:00 PM
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
 
2:00 PM-2:30 PM
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
 
2:30 PM-3:30 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
2:30 PM-3:00 PM
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
 
3:00 PM-3:30 PM
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
 
3:30 PM-3:45 PM - Networking Break
3:45 PM-4:45 PM
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
3:45 PM-4:15 PM
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
 
4:15 PM-5:00 PM
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
 
4:45 PM-5:45 PM
Screen Smarter: Providing Customized, Prioritized Cancer Screening for Your Patients
5:00 PM-5:45 PM
Medical Knowledge: Brain Game
 
 
CLOSE  X  
Registration and Breakfast
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Patient-Centered Medical Home
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Fatty Liver: The Other Obesity-Related Epidemic
Gastroenterology
CLOSE  X  
Thank You for Not Smoking
Lifesaving Interventions
CLOSE  X  
Viral Hepatitis A through E: Advances in Diagnosis and Management
Gastroenterology
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Lifesaving Interventions
CLOSE  X  
Lunch and Additional Opportunities
CLOSE  X  
Test Your Skills in Difficult Cases: Nephrology, Hypertension, and Atrial Fibrillation
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
Infectious Diseases
CLOSE  X  
Infectious Diseases Updates in Primary Care
Infectious Diseases
CLOSE  X  
Networking Break
CLOSE  X  
Maximizing Efficiency: Using Medical Applications in Real Time
CLOSE  X  
Cases in Lipid Management: Controversies and Recommendations
Cardiovascular Risk
CLOSE  X  
New Insights into CV Risk in Patients with Diabetes
Cardiovascular Risk
CLOSE  X  
Women’s Health Update: Clinical Pearls for Primary Care
HRT & Contraception
 
 Curriculum developed in collaboration with
 
 EHR in Primary Practice | Tools, Tips and Cases to Maximize Usability in Your Office
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
3:30PM
 
4:00PM
 
4:30PM
 
5:00PM
 
5:30PM
 
6:30 AM-7:30 AM - Registration and Breakfast
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Patient-Centered Medical Home
 
 
 
8:45 AM-9:30 AM - Networking Break and Additional Opportunities
 
 
9:30 AM-10:30 AM
Fatty Liver: The Other Obesity-Related Epidemic
9:30 AM-10:30 AM
Thank You for Not Smoking
 
 
 
10:30 AM-11:30 AM
Viral Hepatitis A through E: Advances in Diagnosis and Management
10:30 AM-11:30 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
 
 
 
11:30 AM-1:30 PM - Lunch and Additional Opportunities
 
 
 
 
 
 
 
1:30 PM-3:30 PM
Test Your Skills in Difficult Cases: Nephrology, Hypertension, and Atrial Fibrillation
1:30 PM-2:30 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
 
 
 
2:30 PM-3:30 PM
Infectious Diseases Updates in Primary Care
 
 
 
3:30 PM-3:45 PM - Networking Break
3:45 PM-4:45 PM
Maximizing Efficiency: Using Medical Applications in Real Time
3:45 PM-4:45 PM
Cases in Lipid Management: Controversies and Recommendations
 
 
 
4:45 PM-5:45 PM
Women’s Health Update: Clinical Pearls for Primary Care
4:45 PM-5:45 PM
New Insights into CV Risk in Patients with Diabetes
 
 
 
CLOSE  X  
Registration and Breakfast
CLOSE  X  
Welcome and Opening Remarks
CLOSE  X  
Mission Control: Professionalism to Medicine
Faculty:
  1. Story Musgrave, MD
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Setting and Getting to Goal HbA1C Using Combination Therapies
Diabetes: New Options for Achieving Goals
CLOSE  X  
Finding Clinical Value in EHR Meaningful Use
Medical Health Technology: Get On Board or Get Left Behind
CLOSE  X  
An Algorithmic Approach to Insulin Use in Type 2 Diabetes
Diabetes: New Options for Achieving Goals
CLOSE  X  
Social Media and Health Technology Systems for the Practicing Clinician
Medical Health Technology: Get On Board or Get Left Behind
CLOSE  X  
Lunch and Additional Opportunities
CLOSE  X  
Critical Caveats for Common Medications
Patient Safety
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
Pulmonary Medicine and Related Conditions
CLOSE  X  
Keys to Successful Management of Transitions of Care Between the Hospital and Community
Patient Safety
CLOSE  X  
Sleep Apnea Interventions that Will Help You and Your Patient Sleep Better
Pulmonary Medicine and Related Conditions
 
 Curriculum developed in collaboration with
 
 EHR in Primary Practice | Tools, Tips and Cases to Maximize Usability in Your Office
6:30AM
 
7:00AM
 
7:30AM
 
8:00AM
 
8:30AM
 
9:00AM
 
9:30AM
 
10:00AM
 
10:30AM
 
11:00AM
 
11:30AM
 
12:00PM
 
12:30PM
 
1:00PM
 
1:30PM
 
2:00PM
 
2:30PM
 
3:00PM
 
6:30 AM-7:30 AM - Registration and Breakfast
 
 
 
7:30 AM-7:45 AM - Welcome and Opening Remarks
7:45 AM-8:45 AM
Mission Control: Professionalism to Medicine
 
 
 
8:45 AM-9:30 AM - Networking Break and Additional Opportunities
 
 
9:30 AM-10:30 AM
Finding Clinical Value in EHR Meaningful Use
9:30 AM-10:30 AM
Setting and Getting to Goal HbA1C Using Combination Therapies
 
 
 
10:30 AM-11:30 AM
Social Media and Health Technology Systems for the Practicing Clinician
10:30 AM-11:30 AM
An Algorithmic Approach to Insulin Use in Type 2 Diabetes
 
 
 
11:30 AM-1:30 PM - Lunch and Additional Opportunities
 
 
 
 
 
 
 
1:30 PM-2:30 PM
Lung Sounds: A Primer on Pulmonary Auscultation
1:30 PM-2:30 PM
Critical Caveats for Common Medications
 
 
 
2:30 PM-3:30 PM
Sleep Apnea Interventions that Will Help You and Your Patient Sleep Better
2:30 PM-3:30 PM
Keys to Successful Management of Transitions of Care Between the Hospital and Community
 
 
 

Ticketed Events

View Schedule for:

Breakfast

CME Educational Symposia

6:15 AM-7:45 AM

Alzheimer’s Disease

Lunch

CME Educational Symposia

11:45 AM-1:15 PM

Alzheimer’s Disease

Dinner

CME Educational Symposia

6:15 PM-7:45 PM

Alzheimer’s Disease

Lunch

CME Educational Symposia

11:45 AM-1:15 PM

Diabetes
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging – Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
The CME activity is supported by an educational grant from Lilly USA, LLC.
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging – Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
The CME activity is supported by an educational grant from Lilly USA, LLC.
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging – Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
The CME activity is supported by an educational grant from Lilly USA, LLC.
CLOSE  X  
New Avenues in Insulin Therapy: Overcoming Roadblocks in Type 2 Diabetes
Learning Objectives:
  1. Identify 3 priorities of blood glucose pattern management in T2DM
  2. Calculate starting and titration basal insulin doses for patients with T2DM
  3. Explain why avoidance of hypoglycemia should be the highest management priority in T2DM
  4. Compare and contrast the benefits and limitations of stepwise prandial insulin initiation vs premixed insulin initiation in T2DM
  5. Review recent data on investigational insulin therapies
The CME activity is supported by an educational grant from Novo Nordisk Inc..

Accreditation

These educational programs are conceived and created in accordance with Accreditation Council for Continuing Medical Education (ACCME) Accreditation Criteria, the ACCME Standards for Commercial Support, and ACCME Policies. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME’s Advisory Boards and its expert review partner, Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Primary Care Updates
October 15, 2013
Credits Type Accreditation Statement Designation Statement
4.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
Integrated Approaches to Cardiometabolic Care
October 15, 2013
Credits Type Accreditation Statement Designation Statement
4.5 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
Primary Care Updates
October 16, 2013
Credits Type Accreditation Statement Designation Statement
Pending AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
Pending AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for contact hours of continuing education
Annual Conference
October 17—19, 2013
Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pending AAFP Application for CME credit has been filed with American Academy of Family Physicians. Determination of credit is pending.
19 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 19 contact hours of continuing education

Keynote Speakers

Michael Dansinger, MD

Presenting on:

  • Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
    Thursday (October 17, 2013), 7:45 AM-8:45 AM

Story Musgrave, MD

Presenting on:

  • Mission Control: Professionalism to Medicine
    Saturday (October 19, 2013), 7:45 AM-8:45 AM

Exhibit Hall

Exhibitor List

Pri-Med Exhibit Hall

Hours
Thursday, October 17 8:30 AM–2:30 PM
Friday, October 18 8:30 AM–2:30 PM
Saturday, October 19 8:30 AM–2:00 PM

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.


Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.

Exhibitor List

Company Name Booth Number
Accera, Inc. 622
ALCAT 306
Amazing Charts 323
American Express Open 530
Army National Guard 310
Atherotech 107
Bionix Medical Technologies 823
Calmoseptine 718
Carlson Laboratories 506
CryoSurgery, Inc 106
Doximity 410
Elsevier Medical Books 807
Hawaiian Moon 227
HydraFacial MD® - Edge Systems Corp. 617
Janssen Pharmaceuticals, Inc. 315
Lippincott Williams & Wilkins 819
Monthly Prescribing Reference 108
Novartis Pharmaceuticals Corporation 717
Pamlab, LLC 525
Scarf King 123
Shader Productions 326
Take Care Health Systems 624
Teva Respiratory 626
Ultimate Creations 126
ViroPharma Incorporated 406
Vitamix 127
Company Name Booth Number
Aegis Sciences Corporation 207
Amarin Pharma, Inc. 611
American College of Physicians 330
American Latex Allergy Association (ALAA) 307
AstraZeneca 423
Auxilium Pharmaceuticals, Inc. 508
Boehringer Ingelheim Pharmaceuticals, Inc. 623
Cargill 411
CryoProbe 607
Daiichi Sankyo, Inc. 407
Eisai, Inc. 531
HAE: Learn About It, Talk About It 219
Horizon Pharma USA, Inc 619
I.C. E., Inc. 322
Laclede Inc 309
Micro Direct, Inc. 211
Neilmed Pharmaceuticals, Inc. 810
OAPI- Medical Device Division 707
Pfizer Inc. 723
Sensa Products, LLC 311
Summit Doppler Systems 716
Take Shape for Life 314
The Gideons International 222
Verathon Medical 523
Vital Nutrients 811
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Donald E. Stephens Convention Center
5555 North River Road
Rosemont, IL 60018
(847)692-2220
Donald E. Stephens Convention Center web site

Hotel Accommodations